Markets
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Cipla Ltd.
NSE: CIPLA
|
BSE: 500087
|
ISIN: INE059A01026
|
Industry: Pharmaceuticals
|
Mid-range Performer
1329.1000
0.20
(
0.02
%)
NSE
Feb 20, 2026
11:19 AM
Near 52W Low of ₹1281.70
Volume:
302.2K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Cipla Ltd.
31 Oct 2025
1329.10
0.02%
Result Update:Cipla
Buy:
Cipla Ltd.
by
Axis Direct
Target: 1700 | Upside : 27.9%
Axis Direct
We remain positive on the stock with a BUY rating and arrive at a TP of Rs 1,700/share.
Number of FII/FPI investors decreased from 1085 to 1052 in Dec 2025 qtr
More from Cipla Ltd.
Recommended
Market trades higher, Texmaco Rail forms a JV with RVNL to expand EPC project footprint
Trendlyne Marketwatch |
20 Feb 2026, 11:16AM
3 picks: Capex plans and big dreams for three electronics players
The Baseline |
19 Feb 2026, 12:25PM
Indian market boosts Cipla in Q4 despite inventory write-off, new product launches will be key
|
20 May 2022